Contents

Current Cancer Drug Targets, Volume 17 - Number 2


Review Article

Anticancer Potential and Molecular Targets of Pristimerin: A Mini- Review

, 17(2): 100 - 108

Bashir A. Yousef, Hozeifa M. Hassan, Lu-Yong Zhang and Zhen-Zhou Jiang


DOI: 10.2174/1568009616666160112105824



Review Article

Urotensin-II Receptor: A Double Identity Receptor Involved in Vasoconstriction and in the Development of Digestive Tract Cancers and other Tumors

, 17(2): 109 - 121

Alessandro Federico, Silvia Zappavigna, Marcello Dallio, Gabriella Misso, Francesco Merlino, Carmela Loguercio, Ettore Novellino, Paolo Grieco and Michele Caraglia


DOI: 10.2174/1568009616666160621101248



Review Article

Current Development of ROS-Modulating Agents as Novel Antitumor Therapy

, 17(2): 122 - 136

Nan Wang, Yue Wu, Jinlei Bian, Xue Qian, Hongzhi Lin, Haopeng Sun, Qidong You and Xiaojin Zhang


DOI: 10.2174/1568009616666160216125833



Review Article


Review Article

Targeting Key Metabolic Enzymes Involved in Lipid and Protein Biosyntheses for Breast Anticancer Therapies

, 17(2): 158 - 168

Mounia Guerram, Aida Mejda Hamdi, Lu-Yong Zhang and Zhenzhou Jiang


DOI: 10.2174/1568009616666160603123014




Research Article

Grid-independent Descriptors (GRIND) Analysis and SAR Guided Molecular Docking Studies to Probe Selectivity Profiles of Inhibitors of Multidrug Resistance Transporters ABCB1 and ABCG2

, 17(2): 177 - 190

Talha Shafi and Ishrat Jabeen


DOI: 10.2174/1568009616666160901094140



Research Article

CYR61 Confers the Sensitivity to Aromatase Inhibitor Letrozole in ER Positive Breast Carcinoma

, 17(2): 191 - 197

Xiaoqing Jia, Guangyu Liu, Jingyi Cheng, Zhenzhou Shen and Zhimin Shao


DOI: 10.2174/1568009616666160426125058




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science